Totally shares fell 3.5% to 43.9p in late afternoon trading on Tuesday following a reported 12% growth in revenue to £127.4 million in FY 2022 compared to £113.7 million in FY 2021.
The company announced a 24% climb in underlying EBITDA to £6.2 million against £5 million, alongside a rise in pre-tax profit to £1.3 million from £100,000 in the previous year as a result of higher demand for its services.
Totally confirmed an 18% gross margin from an 18.3% gross margin year-on-year, and cash of £15.3 million at 31 March 2022 against £14.8 million.
The firm highlighted an Urgent Care revenue increase of 3.6% to £109.2 million, a Planned Care revenue climb of 43.7% to 7.5 million and an Insourcing Revenue growth to £10.3 million across the financial term.
Totally mentioned a slate of operational high points, including services delivered to 2.5 million patients, £59 million in new contracts including a three-year deal with King’s College NHS Foundation Trust for a new urgent treatment centre, and £72 million in contract extensions.
“During the year, we continued to help manage increasing demand whilst progressing our buy and build strategy to ensure we are positioned strongly to support the NHS and other healthcare providers over the next five to ten years,” said Totally chairman Bob Holt OBE.
“We significantly grew our insourcing capability in response to growing demand, mobilised new services within urgent care, and contributed to strategic projects to improve the delivery of existing service models, such as NHS 111, to ensure that every patient can access the support they need.”
“Everything we do is made possible by the experience and commitment of our teams, whether they are leading the integration of our new businesses or supporting patients on the front line. We thank all of those who work for us, and those we work with, for their continued engagement and commitment to patient care.”
Totally announced an EPS of 0.5p compared to 1p the last year, alongside a total dividend of 1p per share against 0.5p per share for FY 2022.
